Le Lézard
Classified in: Health, Business
Subjects: NPT, PER, VEN

Evio Pharmacy Solutions Established to Tackle Affordability, Outcomes, and Experience with Medications


DENVER, June 22, 2021 /PRNewswire/ -- The clinical benefits of today's pharmacy and specialty drug offerings are truly miraculous. But the real-world evidence to ensure a particular drug is the right medication for each unique patient, how these medications get into the hands of patients, and the costs accrued along the way, remain in need of reform. 

"We must innovate and begin to transform the pharmacy system," Hank Schlissberg, Evio's president and CEO.

"Patient frustration with the system and disparities in health equity are higher than ever. And the price of virtually every prescription drug is roughly double by the time a patient pays for it at the pharmacy counter than it was when the drug was shipped from its manufacturing site ? without transparent benefits to the patient," said Hank Schlissberg, Evio's president and CEO.

Evio, a new independent pharmacy solutions startup, will work to improve medication affordability and patients' clinical outcomes and medication experiences.  Five not-for-profit, mission-driven Blue Cross Blue Shield plans have stepped forward, and each is providing significant funding to support the launch of this new venture. The five plans?Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan, Blue Shield of California, Highmark Inc., and Independence Blue Cross?in total provide coverage to more than 20 million members across the United States.

Initially, Evio will offer services to each of the five investor health plans to complement other innovative medication services the health plans offer. At launch, core focus areas for Evio are:

"We will assemble the best talent, derive greater evidence-based insights from expanded data, capabilities, and resources, and implement new approaches. We will form innovative partnerships across the value chain and vendor community ? all to ensure the right medications get to every patient, simply, affordably, and with superior clinical outcomes," said Schlissberg.

"Evio has a real opportunity to change the trajectory of pharmacy costs, improve clinical outcomes and make it easier for patients to access the medications and treatments they need," said Sandra Clarke, Evio board chair and chief financial officer of Blue Shield California. "We are investing in this innovative venture as part of our ongoing efforts to reduce costs and improve patient experience, and we will continue working alongside our local providers to achieve these goals. We're excited to have a health care veteran of the caliber of Hank Schlissberg, who has 20 years of expertise in health care strategy, operations, and growth, join us as CEO."

"I'm thrilled to bring my health care experience, both professionally and with my family as a long-time specialty pharmacy user, to help lead this venture," said Schlissberg. "We must innovate and begin to transform the pharmacy system."

About Evio
Evio is an independent pharmacy solutions startup that works with health plans to transform the medication experience for everyone: patients, providers, and the system at large. Funded by five not-for-profit health insurers, Evio will enable superior clinical outcomes, reduced costs, and an enhanced experience for patients and providers. Using real world evidence, Evio will ensure every patient gets the right medication in a simple and affordable way. Evio is based in Denver, CO. For more information visit: www.evio.com.

Media Contact:
Andrea LePain
eMedia Junction
[email protected] 
617-275-8112

SOURCE Evio


These press releases may also interest you

at 08:58
Qtrac®, a world-leading provider of queue management and appointment scheduling systems, today announced a partnership with Diversified Purchasing Management Inc. (DPM) that seeks to expand the company's global footprint into Puerto Rico and the...

at 08:57
LGI Healthcare Solutions (LGI), a leader in the development and implementation of healthcare IT solutions, announced its novel and expanded strategic partnership with LiveData, a surgical capacity optimization company....

at 08:55
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of...

at 08:53
According to the Corporate Whistleblower Center, "We have by far the most robust initiative in the nation related to extremely short-staffed long-term care facilities billing Medicare-Medicaid as if they were fully staffed. In August of 2023 we...

at 08:52
Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The presentation will be held at Haakon VIIs gate 2 in Oslo and the event will start at 08.30 CET. A link to the webcast and the presentation will...

at 08:50
Response Pharmaceuticals, Inc., a clinical stage company focused on weight management and metabolic health in high-risk populations, today announced positive topline results from its Phase 1b clinical trial evaluating the safety and efficacy of...



News published on and distributed by: